As conversations around longevity and ‘bio-hacking’ gain momentum, a drug once reserved for highly specific medical use is ...

Physician and seasoned life sciences investor with more than two decades of experience across clinical practice, ...

Longevity experts are turning to technologies and supplements to help extend their lifespan, but how likely are their methods ...

Rapamycin has long been an FDA-approved drug used as an antifungal, and immunosuppressant. However, its use in bio-hacking ...

WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) recently reported its full-year 2025 financial results and outlined ...

Mr. Taylor brings a strong track record launching multiple high-profile therapies, most recently serving as Senior Vice President, Sales at Arcutis Biotherapeutics (Nasdaq: ARQT), where he led U.S. sa ...

Mayo Clinic researchers developed an experimental nanotherapy that delivers two cancer drugs directly to brain tumors, ...

Neuroendocrine cells are unique in their ability to act both as nerve cells and hormone-making cells. They're scattered ...

Efforts to extend life may be succeeding, but not equally. Extending life is only part of the goal in aging research.

WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) recently appointed Jennifer J. McDonough as senior vice president of ...

Researchers at the University of Arizona R. Ken Coit College of Pharmacy will begin a double-blind, randomized Phase 3 ...

MTX240 is a molecular glue, bringing two intracellular proteins, PDE3a and SLFN12, specifically co-expressed by GIST cancer cells, into close proximity to form a stable complex. This interaction ...